Meeting
2017 Gastrointestinal Cancers Symposium
Predictors of survival after trimodality therapy for esophageal adenocarcinoma: Analysis from the National Cancer Database.
Authors
Oliver Eng
City of Hope National Medical Center, Duarte, CA
Oliver Eng , Rebecca A. Nelson , Joseph Chao , Loretta Erhunmwunsee , Dan Raz , Jae Y. Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 35, 2017 (suppl 4S; abstract 116)
DOI
10.1200/JCO.2017.35.4_suppl.116
Abstract #
116
Poster Bd #
J8
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Ten-year overall survival of localized lower thoracic and esophagogastric junction carcinoma receiving trimodality therapy: A National Cancer Database analysis.
First Author: Hanna Kakish
Poster
2018 ASCO Annual Meeting
The population-based impact of adjuvant chemotherapy (CTx) on outcomes in AJCC6 stage IB non-small cell lung cancer (NSCLC).
First Author: Rahul Krishan Arora
Poster
2016 Gastrointestinal Cancers Symposium
The prognostic significance of perineural invasion in patients with esophageal adenocarcinoma treated with neoadjuvant chemoradiotherapy.
First Author: Ankur Kaushik Patel
Poster
2014 Gastrointestinal Cancers Symposium
Clinical response to neoadjuvant therapy to predict success of adjuvant chemotherapy for esophageal adenocarcinoma.
First Author: Vernissia Tam